Serum IFN-γ and IL-10 levels are associated with disease progression in non-obese diabetic mice

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 1, 2002, Pages 64-70

  Schloot, N C ^a   Hanifi Moghaddam, P ^a   Goebel, C ^a   Shatavi, S V ^a   Flohe S ^a   Kolb, H ^a   Rothe, H ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

Cytokines; mRNA; NOD mouse; Serum; Th1 Th2; Type 1 diabetes

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; INSULITIS; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL;

ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; PANCREAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 0036193909     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.256     Document Type: Article

References (34)

1. The pathogenesis of insulin-dependent diabetes mellitus
2. Benign versus destructive insulitis
3. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis
4. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4
5. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?
6. T helper cell subsets in insulin-dependent diabetes
7. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice
8. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus
9. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients
10. Systemic bias of cytokine production towards cell-mediated immune regulation in IDDM and towards humoral immunity in Graves' disease
11. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain
12. Th1-like cytokine production profile and individual specific alterations in TCRBV-gene usage of T cells from newly diagnosed type 1 diabetes patients after stimulation with beta-cell antigens
13. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes
14. Immune markers for monitoring the progression of autoimmune disease
15. Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes
16. Heterophile antimouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes
17. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR
18. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
19. Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice
20. Cytokine secretion patterns in twins discordant for type 1 diabetes
21. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM
22. Th1 to Th2 cytokine shift in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation
23. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10 transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes
24. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
25. A noncytolytic IL-10/ Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
26. Production of interleukin 10 by islet cells accelerates immune mediated destruction of β cells in nonobese diabetic mice
27. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice
28. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity
29. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse
30. Islet antigen-specific T cell clones in autoimmune diabetes: From mice to men
31. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein
32. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus
33. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice
34. Regulation of IFN-gamma mRNA production in murine natural killer cells